Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

April 1, 2018

Conditions

Influenza Virus Vaccine Adverse ReactionInfluenza Vaccine Allergy

Interventions

BIOLOGICAL

Influenza Vaccination

"Influenza vaccination Influsplit Tetra 2016/2017, GlaxoSmithKline GmbH \& Co. KG, Munich, Germany, batch: AFLBA 152AB."

All Listed Sponsors

collaborator

Federal Institute of Sport Science

OTHER

lead

Universität des Saarlandes

OTHER

NCT03654937 - Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes | Biotech Hunter | Biotech Hunter